Docket Room
HR 9418·Federal·house

Access to Innovative Treatments Act of 2026

In CommitteeFiled Jun 24, 2026
Sponsor: Rep. Barragán, Nanette Diaz [D-CA-44] (D)
Latest Action

Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Jun 24, 2026

Summary

Rep. Nanette Diaz Barragán introduced the Access to Innovative Treatments Act of 2026 to address how patients obtain new medical therapies. The measure has been referred to the Ways and Means Committee and the Energy and Commerce Committee for further consideration.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when HR 9418 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice